AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.

Despite a new state law protecting childhood independence, child welfare officials accused these Atlanta parents of ...

Fans see the 2019 episode as the perfect explainer of the current geopolitical situation, helping to drive a resurgence of ...

LOS ANGELES - As I've written in several columns in the Current and in CityWatch LA, the City, County, and LAHSA tend to use ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.

Eli Lilly (LLY) downgraded to Sell as obesity-drug competition and pricing pressure rise; stretched valuation boosts downside ...

The authors present convincing data to validate abscisic acid-induced dimerisation to induce a synthetic spindle assembly checkpoint (SAC) arrest that will be of particular importance to analyse ...

Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...